13F
中

ABEO ABEONA THERAPEUTICS INC

2026Q1 · CUSIP 00289Y206 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
105
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
57
Δ whales
+5
Inst. holding value
$176M
New positions
17
Closed positions
15
Price momentum (1Q)
+6.5%
Put / Call
3/6

Breadth history (34 quarters)

2022Q3: Δ+22 · h=23 2022Q4: Δ+19 · h=42 2023Q1: Δ-8 · h=34 2023Q2: Δ+4 · h=38 2023Q3: Δ+3 · h=41 2023Q4: Δ+8 · h=49 2024Q1: Δ+8 · h=57 2024Q2: Δ-8 · h=49 2024Q3: Δ+7 · h=56 2024Q4: Δ+9 · h=65 2025Q1: Δ+7 · h=72 2025Q2: Δ+23 · h=95 2025Q3: Δ+6 · h=101 2025Q4: Δ+2 · h=103 2026Q1: Δ+2 · h=105 2022Q3: holders=23 2022Q4: holders=42 2023Q1: holders=34 2023Q2: holders=38 2023Q3: holders=41 2023Q4: holders=49 2024Q1: holders=57 2024Q2: holders=49 2024Q3: holders=56 2024Q4: holders=65 2025Q1: holders=72 2025Q2: holders=95 2025Q3: holders=101 2025Q4: holders=103 2026Q1: holders=105 -23 -11.5 +0 +11.5 +23 2066111 22Q322Q423Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 13% -35.6% -25.9%

Options Sentiment

Put holders
3
QoQ: -1
Call holders
6
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
7.4
EPS (TTM)
$0.95
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-06-30: EPS -0.26 2024-09-30: EPS -0.63 2025-03-31: EPS -0.24 2025-06-30: EPS 1.71 2025-09-30: EPS -0.10 2025-12-31: EPS -0.36 2026-03-31: EPS -0.30 -0.69 0.59 1.88 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 6 2025-12-31: PE 52026-03-31: PE 5.8 5 5 6 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)